Susannah G Ellsworth1, Sara R Alcorn2, Russell K Hales1, Todd R McNutt1, Theodore L DeWeese1, Thomas J Smith3. 1. Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: salcorn2@jhmi.edu. 3. Department of Medical Oncology and Harry J. Duffey Family Program in Palliative Care, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
PURPOSE: This study evaluates outcomes and patterns of care among patients receiving radiation therapy (RT) for bone metastases at a high-volume academic institution. METHODS AND MATERIALS: Records of all patients whose final RT course was for bone metastases from April 2007 to July 2012 were identified from electronic medical records. Chart review yielded demographic and clinical data. Rates of complicated versus uncomplicated bone metastases were not analyzed. RESULTS: We identified 339 patients whose final RT course was for bone metastases. Of these, 52.2% were male; median age was 65 years old. The most common primary was non-small-cell lung cancer (29%). Most patients (83%) were prescribed ≤10 fractions; 8% received single-fraction RT. Most patients (52%) had a documented goals of care (GOC) discussion with their radiation oncologist; hospice referral rates were higher when patients had such discussions (66% with vs 50% without GOC discussion, P=.004). Median life expectancy after RT was 96 days. Median survival after RT was shorter based on inpatient as opposed to outpatient status at the time of consultation (35 vs 136 days, respectively, P<.001). Hospice referrals occurred for 56% of patients, with a median interval between completion of RT and hospice referral of 29 days and a median hospice stay of 22 days. CONCLUSIONS: These data document excellent adherence to American Society for Radiation Oncolology Choosing Wisely recommendation to avoid routinely using >10 fractions of palliative RT for bone metastasis. Nonetheless, single-fraction RT remains relatively uncommon. Participating in GOC discussions with a radiation oncologist is associated with higher rates of hospice referral. Inpatient status at consultation is associated with short survival.
PURPOSE: This study evaluates outcomes and patterns of care among patients receiving radiation therapy (RT) for bone metastases at a high-volume academic institution. METHODS AND MATERIALS: Records of all patients whose final RT course was for bone metastases from April 2007 to July 2012 were identified from electronic medical records. Chart review yielded demographic and clinical data. Rates of complicated versus uncomplicated bone metastases were not analyzed. RESULTS: We identified 339 patients whose final RT course was for bone metastases. Of these, 52.2% were male; median age was 65 years old. The most common primary was non-small-cell lung cancer (29%). Most patients (83%) were prescribed ≤10 fractions; 8% received single-fraction RT. Most patients (52%) had a documented goals of care (GOC) discussion with their radiation oncologist; hospice referral rates were higher when patients had such discussions (66% with vs 50% without GOC discussion, P=.004). Median life expectancy after RT was 96 days. Median survival after RT was shorter based on inpatient as opposed to outpatient status at the time of consultation (35 vs 136 days, respectively, P<.001). Hospice referrals occurred for 56% of patients, with a median interval between completion of RT and hospice referral of 29 days and a median hospice stay of 22 days. CONCLUSIONS: These data document excellent adherence to American Society for Radiation Oncolology Choosing Wisely recommendation to avoid routinely using >10 fractions of palliative RT for bone metastasis. Nonetheless, single-fraction RT remains relatively uncommon. Participating in GOC discussions with a radiation oncologist is associated with higher rates of hospice referral. Inpatient status at consultation is associated with short survival.
Authors: James A Tulsky; Robert M Arnold; Stewart C Alexander; Maren K Olsen; Amy S Jeffreys; Keri L Rodriguez; Celette Sugg Skinner; David Farrell; Amy P Abernethy; Kathryn I Pollak Journal: Ann Intern Med Date: 2011-11-01 Impact factor: 25.391
Authors: Daniel Fischberg; Janet Bull; David Casarett; Laura C Hanson; Scott M Klein; Joseph Rotella; Thomas Smith; C Porter Storey; Joan M Teno; Eric Widera Journal: J Pain Symptom Manage Date: 2013-02-22 Impact factor: 3.612
Authors: B Ashleigh Guadagnolo; Kai-Ping Liao; Linda Elting; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih Journal: J Clin Oncol Date: 2012-11-19 Impact factor: 44.544
Authors: Amy S Kelley; Partha Deb; Qingling Du; Melissa D Aldridge Carlson; R Sean Morrison Journal: Health Aff (Millwood) Date: 2013-03 Impact factor: 6.301
Authors: Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag Journal: J Clin Oncol Date: 2013-06-17 Impact factor: 44.544
Authors: Gabrielle B Rocque; Anne E Barnett; Lisa C Illig; Jens C Eickhoff; Howard H Bailey; Toby C Campbell; James A Stewart; James F Cleary Journal: J Oncol Pract Date: 2013-01 Impact factor: 3.840
Authors: Hely Shah; Julian Surujballi; Arif Ali Awan; Brian Hutton; Angel Arnaout; Risa Shorr; Lisa Vandermeer; Mashari Jemaan Alzahrani; Mark Clemons Journal: Breast Cancer Res Treat Date: 2020-11-06 Impact factor: 4.872
Authors: Sara R Alcorn; Christen R Elledge; Jean L Wright; Thomas J Smith; Todd R McNutt; Jacob Fiksel; Scott L Zeger; Theodore L DeWeese Journal: Int J Radiat Oncol Biol Phys Date: 2019-12-02 Impact factor: 7.038
Authors: Raj Satkunasivam; Andre E Kim; Mihir Desai; Mike M Nguyen; David I Quinn; Leslie Ballas; Juan Pablo Lewinger; Mariana C Stern; Ann S Hamilton; Monish Aron; Inderbir S Gill Journal: J Urol Date: 2015-02-21 Impact factor: 7.450
Authors: Jeffrey J Tosoian; Michael A Gorin; Ashley E Ross; Kenneth J Pienta; Phuoc T Tran; Edward M Schaeffer Journal: Nat Rev Urol Date: 2016-10-11 Impact factor: 14.432
Authors: Miriam Vázquez; Manuel Altabas; Diana C Moreno; Abraham A Geng; Santiago Pérez-Hoyos; Jordi Giralt Journal: Front Oncol Date: 2021-04-23 Impact factor: 6.244
Authors: Sebastian M Christ; Markus Schettle; Annina Seiler; Matthias Guckenberger; David Blum; Nicolaus Andratschke; Caroline Hertler Journal: Clin Transl Radiat Oncol Date: 2021-07-04